A Clinical Trial to Evaluate the Efficacy of ConcenTrace to Buffer pH Levels Within the Body.
- Conditions
- pH
- Interventions
- Other: ConcenTrace
- Registration Number
- NCT06122597
- Lead Sponsor
- Trace Minerals
- Brief Summary
This virtual single-arm trial will last 12 weeks. Participants will take the drops daily and complete questionnaires at Baseline, Week 4, Week 8, and Week 12.
Urine pH measurements will be taken at Baseline, Week 4, Week 8, and Week 12 using pH test strips.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Male or female. Aged 18+. Generally healthy - don't live with any uncontrolled disease. Willing to maintain their standard dietary pattern, activity level, and body weight for the duration of the study.
- Anyone with a pre-existing chronic condition that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
Anyone with known severe allergic reactions. Women who are pregnant, breastfeeding, or attempting to become pregnant. Anyone unwilling to follow the study protocol.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Test arm: ConcenTrace ConcenTrace Participants should follow this weekly dosing schedule: Week 1 - Days 1-3: take 5 drops of ConcenTrace with 8 oz of water or flavored water. Days 4-7: take 5 drops of ConcenTrace 2x daily with 8 oz of water or flavored water. Week 2: Take 10 drops of ConcenTrace 2x daily with 8 oz of water or flavored water. Week 3: Take 15 drops of ConcenTrace 2x daily with 8 oz of water or flavored water. Weeks 4-12: Take 20 drops of ConcenTrace 2x daily with 8 oz of water or flavored water.
- Primary Outcome Measures
Name Time Method Changes in urine pH levels. [Timeframe: Baseline to Week 12] 12 weeks Participants will use pH test strips to measure urine pH. Changes in urine pH will be evaluated.
- Secondary Outcome Measures
Name Time Method Change in score on the Metabolic Screening Questionnaire. 12 weeks A Metabolic Screening Questionnaire (MSQ) was developed by the Toronto Centre for Naturopathic Medicine. The symptoms represented on a MSQ represent symptoms commonly associated with inflammation and toxicity. Participants will rate frequency and intensity of applicable symptoms according to the following scores:
* Absent or rare symptoms - 0 points
* Occasional, mild symptoms - 1 point
* Occasional, severe symptoms - 2 points
* Frequent, mild symptoms - 3 points
* Frequent, severe symptoms - 4 points
Trial Locations
- Locations (1)
Citruslabs
🇺🇸Santa Monica, California, United States